Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trial

Inês Aguiar-Neves, Sílvia O Diaz, João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, Beatrice Mariottoni, Franco Cosmi, Mark Hazebroek, Job A.J. Verdonschot, Joe Cuthbert, Johannes Petutschnigg, Stephane Heymans, Jan A Staessen, Burkert Pieske, Frank Edelmann, Andrew L Clark, Patrick Rossignol, Ricardo Fontes-Carvalho, John G Cleland, Faiez Zannad

Open source

DOI: 10.1016/j.repc.2025.12.010
Published: 2026-03
Container: Revista Portuguesa de Cardiología
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.repc.2025.12.010,
  title = {Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trial},
  author = {Inês Aguiar-Neves and Sílvia O Diaz and João Pedro Ferreira and Nicolas Girerd and Pierpaolo Pellicori and Beatrice Mariottoni and Franco Cosmi and Mark Hazebroek and Job A.J. Verdonschot and Joe Cuthbert and Johannes Petutschnigg and Stephane Heymans and Jan A Staessen and Burkert Pieske and Frank Edelmann and Andrew L Clark and Patrick Rossignol and Ricardo Fontes-Carvalho and John G Cleland and Faiez Zannad},
  year = {2026},
  journal = {Revista Portuguesa de Cardiología},
  doi = {10.1016/j.repc.2025.12.010},
  url = {https://doi.org/10.1016/j.repc.2025.12.010}
}

RIS

TY  - JOUR
TI  - Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trial
AU  - Inês Aguiar-Neves
AU  - Sílvia O Diaz
AU  - João Pedro Ferreira
AU  - Nicolas Girerd
AU  - Pierpaolo Pellicori
AU  - Beatrice Mariottoni
AU  - Franco Cosmi
AU  - Mark Hazebroek
AU  - Job A.J. Verdonschot
AU  - Joe Cuthbert
AU  - Johannes Petutschnigg
AU  - Stephane Heymans
AU  - Jan A Staessen
AU  - Burkert Pieske
AU  - Frank Edelmann
AU  - Andrew L Clark
AU  - Patrick Rossignol
AU  - Ricardo Fontes-Carvalho
AU  - John G Cleland
AU  - Faiez Zannad
PY  - 2026
JO  - Revista Portuguesa de Cardiología
DO  - 10.1016/j.repc.2025.12.010
UR  - https://doi.org/10.1016/j.repc.2025.12.010
ER  -

APA

Aguiar-Neves, I., Diaz, S. O., Ferreira, J. P., Girerd, N., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Rossignol, P., Fontes-Carvalho, R., Cleland, J. G., & Zannad, F. (2026). Health status and effects of spironolactone in people at high risk of heart failure: the Heart OMics in AGEinging (HOMAGE) randomized trial. Revista Portuguesa de Cardiología. https://doi.org/10.1016/j.repc.2025.12.010

Source records

hal · retrieved 2026-09-25T09:25:54.794Z